Reversing non-formulary status will usually require new data. The message developed in this article is that for products not on a hospital’s formulary, getting on formulary goes beyond what might be ...

The use of pharmacoeconomic data in hospital formulary decisions was explored. Data were collected from pharmacist members of pharmacy and therapeutics (P&T) committees in 204 Florida hospitals.

Successful formulary system management can help ACOs achieve high quality, low cost objectives across the care continuum. This article targets healthcare leaders choosing to participate in the ...

Healthcare lease accounting insights: How two organizations got compliant and stay audit-ready all year long Healthcare organizations (HCOs) often hold multiple leases such as those for real estate, ...

Why the time is right for P&T committees to incorporate real-world data and ‘real-world science’ into their product assessments. The spiraling cost of prescription drugs is creating unprecedented ...

Pharmacy benefit manager Express Scripts announced Dec. 12 the creation of a formulary to increase provider trust in and patient access to digital and mobile health apps and devices, including those ...

Methods:We analyzed data from 8 Departmentof Veterans Affairs medical centers and7 nonfederal US hospitals. At each hospital,we randomly sampled 200 ARI visits withdischarge diagnoses for ...

With the clinical and financial implications of high-cost medications, and their impact on health system revenue, it is of utmost importance for all key stakeholders to be engaged in the complex ...

Oral phosphodiesterase type 5 (PDE5) inhibitors are the recommended first-line option for the treatment of erectile dysfunction. Currently, three PDE5 inhibitors are approved for use in the United ...